Wells Fargo taps AWS’s Faraz Shafiq for AI leadership and attracts $8.6M stake
On Feb. 9, Wells Fargo will install AWS veteran Faraz Shafiq as head of AI products and solutions, overseeing enterprise-wide generative and agentic AI roadmap under co-CEO Saul Van Beurden. Separately, Commerzbank Aktiengesellschaft FI acquired 102,542 shares of Wells Fargo, a $8.6 million stake signaling institutional confidence.
1. Wells Fargo Appoints Faraz Shafiq as Head of AI Products and Solutions
Wells Fargo has named Faraz Shafiq, currently field chief technology officer for generative and agentic AI at Amazon Web Services, to lead its AI products and solutions organization, effective February 9. Reporting to Saul Van Beurden, head of AI and co-CEO of Consumer Banking and Lending, Shafiq will oversee the vision, roadmap and development of AI-powered tools for the bank’s four operating segments. Shafiq brings more than 15 years of technology leadership experience at AWS, Verizon, AT&T and Google. Charlie Scharf, Wells Fargo’s chairman and CEO, noted that the bank has already trained over 90,000 employees on AI, deployed tools to more than 180,000 desktops and boosted engineer coding efficiency by 30–35%. The appointment underscores Wells Fargo’s strategy to scale generative and agentic AI capabilities to improve customer service, risk management and operational productivity.
2. Commerzbank Aktiengesellschaft FI Acquires Stake in Wells Fargo
In its latest SEC filing, Commerzbank Aktiengesellschaft FI reported the acquisition of 102,542 shares of Wells Fargo during the third quarter, representing a new position valued at approximately $8.60 million. This move adds to a wave of institutional activity, with Access Investment Management LLC, Marquette Asset Management LLC and Grey Fox Wealth Advisors LLC also establishing or expanding positions in Wells Fargo. Institutional investors now hold 75.90% of the company’s shares. Analysts continue to weigh in on Wells Fargo’s prospects: Keefe, Bruyette & Woods raised its objective to $101 and maintained a market perform rating, while Cfra Research upgraded to moderate buy. As of the end of December, thirteen research firms rated the stock a Buy, nine a Hold and one a Sell, reflecting a consensus moderate buy outlook.